Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C (HCV)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableNo Longer AvailableNCT02097966
What this trial is testing

EU: A Multicenter Compassionate Use Program of Daclatasvir (BMS-790052) in Combination With Sofosbuvir With or Without Ribavirin for the Treatment of Subjects With Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb
Large-scale testing (Phase 3)Study completedNCT02219490
What this trial is testing

Evaluate Long-term Outcomes Following Treatment With ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) and ABT-333 With or Without Ribavirin (RBV) in Adults With Genotype 1 Chronic Hepatitis C Virus (HCV) Infection

Who this might be right for
Chronic Hepatitis C Virus (HCV) Infection Genotype 1
AbbVie 1,596
Post-approval studies (Phase 4)Study completedNCT00881582
What this trial is testing

Peginterferon Alfa-2a Plus Ribavirin Combination Treatment in Chronic Hepatitis C Post-Renal Transplant Patients

Who this might be right for
Chronic Hepatitis CRenal Transplant
King Abdulaziz Medical City 32
Large-scale testing (Phase 3)Study completedNCT02609659
What this trial is testing

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir With Low-Dose Ribavirin QD in Subjects With Genotype 1a Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus (HCV)
AbbVie 105
Post-approval studies (Phase 4)Study completedNCT00560274
What this trial is testing

NeoRecormon (Epoetin Beta) in Anemic Patients With Chronic Hepatitis C.

Who this might be right for
Anemia
Hoffmann-La Roche 190
Early research (Phase 1)Study completedNCT01438320
What this trial is testing

Q-Trial in Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis C
University of California, Los Angeles 34
Testing effectiveness (Phase 2)Study completedNCT00277238
What this trial is testing

CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects

Who this might be right for
Hepatitis, Chronic Active
Pfizer 113
Post-approval studies (Phase 4)Study completedNCT00087568
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Combination With Ribavirin in Patients With Chronic Hepatitis C (CHC) Previously Treated With PEG-Intron + Ribavirin

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 57
Testing effectiveness (Phase 2)Study completedNCT01074008
What this trial is testing

Study to Evaluate the Safety, Tolerability and Antiviral Activity of ABT-450, ABT-333 and ABT-072

Who this might be right for
Hepatitis CHCVChronic Hepatitis C Infection+1 more
AbbVie (prior sponsor, Abbott) 74
Testing effectiveness (Phase 2)Study completedNCT01180790
What this trial is testing

Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants

Who this might be right for
Hepatitis C
Alexion Pharmaceuticals, Inc. 122
Not applicableStudy completedNCT03594838
What this trial is testing

Evaluation of HCV Viremia Testing Approaches Among PWID in Georgia

Who this might be right for
Hepatitis C, Chronic
Foundation for Innovative New Diagnostics, Switzerland 1,672
Testing effectiveness (Phase 2)Study completedNCT02468648
What this trial is testing

Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816

Who this might be right for
Chronic Hepatitis C
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 72
Not applicableStudy completedNCT05568576
What this trial is testing

Metabolic Syndrome and Long-term Survival Following Liver Resection

Who this might be right for
Survival
Assiut University 70
Not applicableEnded earlyNCT02590068
What this trial is testing

Effects of Chronic Viral Infection on Immune Response to Zoster Vaccination

Who this might be right for
Hepatitis C
Rockefeller University 14
Early research (Phase 1)WithdrawnNCT00255359
What this trial is testing

Safety, Tolerability and Efficacy of XTL 2125 in HCV-Infected Patients Who Are Interferon-Alpha Non-Responders or Relapsers

Who this might be right for
Chronic Hepatitis C Virus Infection
Hadassah Medical Organization 60
Large-scale testing (Phase 3)Study completedNCT01732796
What this trial is testing

IFN-free Combination Therapy in HCV-infected Patients Treatment-naive:HCVerso1

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 470
Post-approval studies (Phase 4)Study completedNCT02804386
What this trial is testing

Efficacy and Safety of Zoval (Sofosbuvir) and Ribavirin With or Without Interferon

Who this might be right for
Hepatitis C, Chronic
PharmEvo Pvt Ltd 573
Not applicableStudy completedNCT02537379
What this trial is testing

Use-Results Surveillance Study of Sovaldi® Plus Copegus® in Japanese Patients With Chronic Genotype 2 Hepatitis C Virus Infection

Who this might be right for
Hepatitis C Virus Infection
Gilead Sciences 552
Large-scale testing (Phase 3)Study completedNCT02247401
What this trial is testing

Coadministration of ABT-450/Ritonavir/ABT-267 (ABT-450/r/ABT-267) With Ribavirin (RBV) in Adults With Genotype 4 (GT4) Hepatitis C Virus (HCV) in Egypt

Who this might be right for
HCVHepatitis C InfectionGenotype 4
AbbVie 160
Post-approval studies (Phase 4)Ended earlyNCT00255034
What this trial is testing

Effects of 48 Weeks Versus 24 Weeks of Therapy With Peg-Intron/Ribavirin in Patients With Chronic Hepatitis C, Genotype 3 (Study P04143)(TERMINATED)

Who this might be right for
Hepatitis C, Chronic
Merck Sharp & Dohme LLC 146
Next Page